P. Lévy, M. Kohler, W. T. Mcnicholas, F. Barbé, R. D. Mcevoy et al., Obstructive sleep apnoea syndrome, Nat Rev Dis Primers, vol.1, p.15015, 2015.

P. E. Peppard, T. Young, M. Palta, and J. Skatrud, Prospective study of the association between sleep-disordered breathing and hypertension, N Engl J Med, vol.342, pp.1378-84, 2000.

Y. Peker, H. Kraiczi, J. Hedner, S. Löth, A. Johansson et al., An independent association between obstructive sleep apnoea and coronary artery disease

, Eur Respir J, vol.14, pp.179-84, 1999.

M. Arzt, T. Young, L. Finn, J. B. Skatrud, and T. D. Bradley, Association of sleepdisordered breathing and the occurrence of stroke, Am J Respir Crit Care Med, vol.172, pp.1447-51, 2005.

D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy et al., Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Circulation, vol.117, pp.510-536, 2008.

S. F. Rimoldi, F. H. Messerli, S. Bangalore, and U. Scherrer, Resistant hypertension: what the cardi ol ogist needs to know, Eur Heart J, vol.36, pp.2686-95, 2015.

R. P. Pedrosa, L. F. Drager, C. C. Gonzaga, M. G. Sousa, L. De-paula et al., Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension, Hypertension, vol.58, pp.811-818, 2011.

S. C. Gonçalves, D. Martinez, G. M. De-abreu-silva, E. O. Bertoluci, C. Dutra et al., Obstructive sleep apnea and resistant hypertension: a case-control study, Chest, vol.132, pp.1858-62, 2007.

A. P. De-faria, R. Modolo, V. Fontana, and H. Moreno, Adipokines: novel players in resistant hypertension, J Clin Hypertens, vol.16, pp.754-763, 2014.

A. P. De-faria, A. Ritter, A. R. Sabbatini, R. Modolo, and H. Moreno, Effects of leptin and leptin receptor SNPs on clinical-and metabolic-related traits in apparent treatment-resistant hypertension, vol.26, pp.74-80, 2017.

A. De-faria, C. Demacq, V. N. Figueiredo, C. H. Moraes, R. C. Santos et al., Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension, Hypertens Res, vol.36, pp.1067-72, 2013.

C. De-haro-moraes, V. N. Figueiredo, A. De-faria, N. R. Barbaro, A. R. Sabbatini et al., High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension, J Hum Hypertens, vol.27, pp.225-255, 2013.

A. R. Sabbatini, A. P. Faria, N. R. Barbaro, W. M. Gordo, R. Modolo et al., Deregulation of adipokines related to target organ damage on resistant hypertension, J Hum Hypertens, vol.28, pp.388-92, 2014.

C. A. Feldstein, Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials, Clin Exp Hypertens, vol.38, pp.337-383, 2016.

L. Liu, Q. Cao, Z. Guo, and Q. Dai, Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: a meta-analysis of randomized controlled trials, J Clin Hypertens, vol.18, pp.153-161, 2016.

L. Lozano, J. L. Tovar, G. Sampol, O. Romero, M. J. Jurado et al., Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial, J Hypertens, vol.28, pp.2161-2169, 2010.

M. Martínez-garcía, F. Capote, F. Campos-rodríguez, P. Lloberes, D. De-atauri et al., Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial, JAMA, vol.310, pp.2407-2422, 2013.

R. P. Pedrosa, L. F. Drager, L. De-paula, A. Amaro, L. A. Bortolotto et al., Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial, Chest, vol.144, pp.1487-94, 2013.

E. S. Muxfeldt, V. Margallo, L. Costa, G. Guimarães, A. H. Cavalcante et al., Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial, Hypertension, vol.65, pp.736-778, 2015.

A. C. De-oliveira, D. Martinez, D. Massierer, M. Gus, S. C. Gonçalves et al., The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial, Am J Respir Crit Care Med, vol.190, pp.345-352, 2014.

M. Sánchez-de-la-torre, A. Khalyfa, A. Sánchez-de-la-torre, M. Martinez-alonso, M. Á. Martinez-garcía et al., Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment, J Am Coll Cardiol, vol.66, pp.1023-1055, 2015.

J. Pépin, R. Tamisier, G. Barone-rochette, S. H. Launois, P. Lévy et al., Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea, Am J Respir Crit Care Med, vol.182, pp.954-60, 2010.

R. B. Berry, R. Budhiraja, D. J. Gottlieb, D. Gozal, C. Iber et al., Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine, J Clin Sleep Med, vol.8, pp.597-619, 2012.

T. G. Pickering, J. E. Hall, L. J. Appel, B. E. Falkner, J. Graves et al., Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on high blood pressure research, Hypertension, vol.45, pp.142-61, 2005.

D. J. Bratton, T. Gaisl, A. M. Wons, and M. Kohler, CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis, JAMA, vol.314, pp.2280-93, 2015.

H. F. Becker, A. Jerrentrup, T. Ploch, L. Grote, T. Penzel et al., Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea, Circulation, vol.107, pp.68-73, 2003.

G. Mancia, D. Backer, G. Dominiczak, A. Cifkova, R. Fagard et al., guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the, European Society of Cardiology, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02042310

, J Hypertens, vol.25, pp.1105-87, 2007.

A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group, Ann Intern Med, vol.130, pp.461-70, 1999.

K. G. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome -a new world-wide definition. A consensus statement from the international diabetes federation, Diabet Med, vol.23, pp.469-80, 2006.

C. Meunier, D. Blondelle, P. Faure, J. Baguet, L. Goff et al., Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS, Clin Chim Acta, vol.447, pp.8-15, 2015.

R. Farré, L. Hernández, J. M. Montserrat, M. Rotger, E. Ballester et al., Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea, Lancet, vol.353, p.1154, 1999.

M. Calvert, J. Blazeby, D. G. Altman, D. A. Revicki, D. Moher et al., Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension, JAMA, vol.309, pp.814-836, 2013.

M. R. Crawford, D. J. Bartlett, S. R. Coughlin, C. L. Phillips, A. M. Neill et al., The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: real effects or expectation of benefit?, Thorax, vol.67, pp.920-924, 2012.

A. G. Logan, S. M. Perlikowski, A. Mente, A. Tisler, R. Tkacova et al., High prevalence of unrecognized sleep apnoea in drug-resistant hypertension, J Hypertens, vol.19, pp.2271-2278, 2001.

B. Abuyassin, K. Sharma, N. T. Ayas, and I. Laher, Obstructive sleep apnea and kidney disease: a potential bidirectional relationship?, J Clin Sleep Med, vol.11, pp.915-939, 2015.

G. Parati, C. Lombardi, J. Hedner, M. R. Bonsignore, L. Grote et al., Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea, J Hypertens, vol.30, pp.633-679, 2012.

E. Tasali and M. Ip, Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation, Proc Am Thorac Soc, vol.5, pp.207-224, 2008.

J. C. Lam, J. C. Mak, and M. S. Ip, Obesity, obstructive sleep apnoea and metabolic syndrome, Respirology, vol.17, pp.223-259, 2012.

A. De-faria, V. Fontana, R. Modolo, N. R. Barbaro, A. R. Sabbatini et al., Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension, Clin Chim Acta, vol.433, pp.179-83, 2014.

A. R. Sabbatini, V. Fontana, S. Laurent, and H. Moreno, An update on the role of adipokines in arterial stiffness and hypertension, J Hypertens, vol.33, pp.435-479, 2015.

M. S. Ip, K. S. Lam, C. Ho, K. W. Tsang, and W. Lam, Serum leptin and vascular risk factors in obstructive sleep apnea, Chest, vol.118, pp.580-586, 2000.

I. A. Harsch, P. C. Konturek, C. Koebnick, P. P. Kuehnlein, F. S. Fuchs et al., Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment, Eur Respir J, vol.22, pp.251-258, 2003.

N. Mcardle, D. Hillman, L. Beilin, and G. Watts, Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study, Am J Respir Crit Care Med, vol.175, pp.190-195, 2007.

F. Kapsimalis, G. Varouchakis, A. Manousaki, S. Daskas, D. Nikita et al., Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea, Lung, vol.186, pp.209-226, 2008.

H. Schäfer, D. Pauleit, T. Sudhop, I. Gouni-berthold, S. Ewig et al., Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea, Chest, vol.122, pp.829-868, 2002.

S. R. Patel, L. J. Palmer, E. K. Larkin, N. S. Jenny, D. P. White et al., Relationship between obstructive sleep apnea and diurnal leptin rhythms, Sleep, vol.27, pp.235-244, 2004.

K. Spiegel, R. Leproult, L. 'hermite-balériaux, M. Copinschi, G. Penev et al., Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin, J Clin Endocrinol Metab, vol.89, pp.5762-71, 2004.

D. A. Calhoun and S. M. Harding, Sleep and hypertension, Chest, vol.138, pp.434-477, 2010.

D. C. Genta-pereira, R. P. Pedrosa, G. Lorenzi-filho, and L. F. Drager, Sleep disturbances and resistant hypertension: association or causality?, Curr Hypertens Rep, vol.16, p.459, 2014.

S. Sharma and M. Kavuru, Sleep and metabolism: an overview, Int J Endocrinol, p.270832, 2010.

O. Friedman, T. D. Bradley, P. Ruttanaumpawan, and A. G. Logan, Independent association of drug-resistant hypertension to reduced sleep duration and efficiency, Am J Hypertens, vol.23, pp.174-183, 2010.

A. L. Mark, K. Rahmouni, M. Correia, and W. G. Haynes, A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat, Acta Physiol Scand, vol.177, pp.345-354, 2003.

E. Dolan, A. Stanton, L. Thijs, K. Hinedi, N. Atkins et al., Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study, Hypertension, vol.46, pp.156-61, 2005.

M. W. Gillman, W. B. Kannel, A. Belanger, D. Agostino, and R. B. , Influence of heart rate on mortality among persons with hypertension: the Framingham study, Am Heart J, vol.125, issue.93, p.90128, 1993.

P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, M. P. Telera et al., Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension, J Hypertens, vol.16, pp.1335-1378, 1998.

S. E. Craig, M. Kohler, D. Nicoll, D. J. Bratton, A. Nunn et al., Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial, Thorax, vol.67, pp.1090-1096, 2012.